Primary ovarian insufficiency: A more accurate term for premature ovarian failure

Clinical Endocrinology

Volumn 68, Issue 4, 2008, Pages 499-509

  Welt, Corrine K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FOLLITROPIN; LUTEINIZING HORMONE; PROCARBAZINE;

AIRE GENE; ARTICLE; ATM GENE; AUTOIMMUNE DISEASE; BLM GENE; BLOOM SYNDROME; CHROMOSOME ABERRATION; CLINICAL FEATURE; CYP17A1 GENE; DISEASE ASSOCIATION; DISEASE COURSE; EIF2B 2 GENE; EIF2B 4 GENE; EIF2B 5 GENE; FEMALE; FOXL2 GENE; FSHR GENE; GALT GENE; GENE; GENE MUTATION; HUMAN; IATROGENIC DISEASE; INHA GENE; LHCGR GENE; MOUSE; NONHUMAN; OVARY FUNCTION; OVARY INSUFFICIENCY; POLG GENE; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; SYMPTOMATOLOGY; TURNER SYNDROME;

FEMALE; HUMANS; OVARIAN FAILURE, PREMATURE;

EID: 40749100654     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03073.x     Document Type: Article

References (101)

1. Baker, T.G. (1963) A quantitative and cytological study of germ cells in human ovaries. Proceedings of the Royal Society of London. Series B, Containing Papers of a Biology Character, 158, 417 433.
2. Faddy, M.J. (2000) Follicle dynamics during ovarian ageing. Molecular and Cellular Endocrinology, 163, 43 48.
3. Nikolaou, D. Templeton, A. (2004) Early ovarian ageing. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 113, 126 133.
4. Farhi, J., Homburg, R., Ferber, A., Orvieto, R. Ben, R.Z. (1997) Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Human Reproduction, 12, 241 243.
5. Nikolaou, D., Lavery, S., Turner, C., Margara, R. Trew, G. (2002) Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Human Reproduction, 17, 1106 1111.
6. de Boer, E.J., den, T.I., te Velde, E.R., Burger, C.W. van Leeuwen, F.E. (2003) Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Human Reproduction, 18, 1544 1552.
7. Rebar, R.W., Erickson, G.F. Yen, S.S. (1982) Idiopathic premature ovarian failure: clinical and endocrine characteristics. Fertility and Sterility, 37, 35 41.
8. Nelson, L.M., Anasti, J.N., Kimzey, L.M., Defensor, R.A., Lipetz, K.J., White, B.J., Shawker, T.H. Merino, M.J. (1994) Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. Journal of Clinical Endocrinology and Metabolism, 79, 1470 1475.
9. Taylor, A.E., Adams, J.M., Mulder, J.E., Martin, K.A., Sluss, P.M. Crowley, Jr (1996) W.F. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. Journal of Clinical Endocrinology and Metabolism, 81, 3615 3621.
10. van Kasteren, Y.M. Schoemaker, J. (1999) Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Human Reproduction Update, 5, 483 492.
11. Albright, F., Smith, P.H. Fraser, R. (1942) A syndrome characterized by primary ovarian insufficiency and decreased stature. American Journal of the Medical Sciences, 204, 625 648.
12. Armstrong, A.Y., Calis, K.A. Nelson, L.M. (2007) Do survivors of childhood cancer have an increased incidence of primary ovarian insufficiency? Nature Clinical Practice Endocrinology and Metabolism, 3, 326 327.
13. Popat, V.B., Vanderhoof, V.H., Calis, K.A., Troendle, J.F. Nelson, L.M. (2007) Normalization of serum luteinizing hormone levels in women with 46,XX spontaneous primary ovarian insufficiency. Fertility and Sterility, epub ahead of print (doi:).
14. Nelson, L.M. (2006) FMR1 Premutation and Premature Ovarian Failure: Worldwide Community Guideline Development. Available at: http://www.fmr1pof.com. New Orleans, LA.
15. Sybert, V.P. McCauley, E. (2004) Turner's syndrome. New England Journal of Medicine, 351, 1227 1238.
16. Singh, R.P. Carr, D.H. (1966) The anatomy and histology of XO human embryos and fetuses. Anatomical Record, 155, 369 383.
17. Cunniff, C., Jones, K.L. Benirschke, K. (1991) Ovarian dysgenesis in individuals with chromosomal abnormalities. Human Genetics, 86, 552 556.
18. Modi, D.N., Sane, S. Bhartiya, D. (2003) Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads. Molecular Human Reproduction, 9, 219 225.
19. Devi, A.S., Metzger, D.A., Luciano, A.A. Benn, P.A. (1998) 45,X/46,XX mosaicism in patients with idiopathic premature ovarian failure. Fertility and Sterility, 70, 89 93.
20. Rao, E., Weiss, B., Fukami, M., Rump, A., Niesler, B., Mertz, A., Muroya, K., Binder, G., Kirsch, S., Winkelmann, M., Nordsiek, G., Heinrich, U., Breuning, M.H., Ranke, M.B., Rosenthal, A., Ogata, T. Rappold, G.A. (1997) Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nature Genetics, 16, 54 63.
21. Prueitt, R.L. Zinn, A.R. (2002) Genetics of premature ovarian failure. In : M. Filicori ed. Advances in Infertility Treatment. Monduzzi Editore, Bologna, Italy, 51 67.
22. Gravholt, C.H., Fedder, J., Naeraa, R.W. Muller, J. (2000) Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. Journal of Clinical Endocrinology and Metabolism, 85, 3199 3202.
23. Schlessinger, D., Herrera, L., Crisponi, L., Mumm, S., Percesepe, A., Pellegrini, M., Pilia, G. Forabosco, A. (2002) Genes and translocations involved in POF. American Journal of Medical Genetics, 111, 328 333.
24. Bione, S., Sala, C., Manzini, C., Arrigo, Z., Zuffardi, O., Banfi, S., Borsani, G., Jenveaux, P., Philippe, C., Zuccotti, M., Ballabio, A. Toniolo, D. (1998) A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. American Journal of Human Genetics, 62, 533 541.
25. Prueitt, R.L., Chen, H., Barnes, R.I. Zinn, A.R. (2002) Most X; autosome translocations associated with premature ovarian failure do not interrupt X-linked genes. Cytogenetic and Genome Research, 97, 32 38.
26. Marozzi, A., Manfredini, E., Tibiletti, M.G., Furlan, D., Villa, N., Vegetti, W., Crosignani, P.G., Ginelli, E., Meneveri, R. Dalpra, L. (2000) Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Human Genetics, 107, 304 311.
27. Galloway, S.M., McNatty, K.P., Cambridge, L.M., Laitinen, M.P., Juengel, J.L., Jokiranta, T.S., McLaren, R.J., Luiro, K., Dodds, K.G., Montgomery, G.W., Beattie, A.E., Davis, G.H. Ritvos, O. (2000) Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nature Genetics, 25, 279 283.
28. Di, P.E., Beck-Peccoz, P. Persani, L. (2004) Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. American Journal of Human Genetics, 75, 106 111.
29. Di, P.E., Rossetti, R., Marozzi, A., Bodega, B., Borgato, S., Cavallo, L., Einaudi, S., Radetti, G., Russo, G., Sacco, M., Wasniewska, M., Cole, T., Beck-Peccoz, P., Nelson, L.M. Persani, L. (2006) Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. Journal of Clinical Endocrinology and Metabolism, 91, 1976 1979.
30. Oberle, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boue, J., Bertheas, M.F. Mandel, J.L. (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science, 252, 1097 1102.
31. Verkerk, A.J., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F.P., Eussen, B.E., van Ommen, G.B., Blonden, L.A.J., Riggins, G.J., Chastain, J.L., Kunst, C.B., Galjaard, H., Caskey, C.T., Nelson, D.L., Oostra, B.A. Warran, S.T. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65, 905 914.
32. Fu, Y.H., Kuhl, D.P., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkerk, A.J., Holden, J.J., Fenwick, R.G. Jr., Warren, S.T., Oostra, B.A., Nelson, D.L. Caskey, C.T. (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell, 67, 1047 1058.
33. Sullivan, A.K., Marcus, M., Epstein, M.P., Allen, E.G., Anido, A.E., Paquin, J.J., Yadav-Shah, M. Sherman, S.L. (2005) Association of FMR1 repeat size with ovarian dysfunction. Human Reproduction, 20, 402 412.
34. Welt, C.K., Smith, P.C. Taylor, A.E. (2004) Evidence of early ovarian aging in fragile X premutation carriers. Journal of Clinical Endocrinology and Metabolism, 89, 4569 4574.
35. Tassone, F., Hagerman, R.J., Taylor, A.K., Gane, L.W., Godfrey, T.E. Hagerman, P.J. (2000) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. American Journal of Human Genetics, 66, 6 15.
36. Hagerman, R.J., Leehey, M., Heinrichs, W., Tassone, F., Wilson, R., Hills, J., Grigsby, J., Gage, B. Hagerman, P.J. (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology, 57, 127 130.
37. Wittenberger, M.D., Hagerman, R.J., Sherman, S.L., Conkie-Rosell, A., Welt, C.K., Rebar, R.W., Corrigan, E.C., Simpson, J.L. Nelson, L.M. (2006) The FMR1 premutation and reproduction. Fertility and Sterility, 87, 456 465.
38. American College of Obstetrics Gynecology 2006) ACOG committee opinion, 338: Screening for fragile X syndrome. Obstetrics and Gynecology, 107, 1483 1485.
39. Sherman, S., Pletcher, B.A. Driscoll, D.A. (2005) Fragile X syndrome: diagnostic and carrier testing. Genetics in Medicine, 7, 584 587.
40. Murray, A., Webb, J., Dennis, N., Conway, G. Morton, N. (1999) Microdeletions in FMR2 may be a significant cause of premature ovarian failure. Journal of Medical Genetics, 36, 767 770.
41. Segal, S. Berry, G.T. (1995) Disorders of galactose metabolism. In : C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle eds. The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, Inc., New York, 967 1000.
42. Kaufman, F.R., Kogut, M.D., Donnell, G.N., Goebelsmann, U., March, C. Koch, R. (1981) Hypergonadotropic hypogonadism in female patients with galactosemia. New England Journal of Medicine, 17, 994 998.
43. Levy, H.L., Driscoll, S.G., Porensky, R.S. Wender, D.F. (1984) Ovarian failure in galactosemia. New England Journal of Medicine, 310, 50.
44. Gibson, J.B. (1995) Gonadal function in galacotsemics and in galactose-intoxicated animals. European Journal of Pediatrics, 154, S14 S20.
45. Meyer, W.R., Doyle, M.B., Grifo, J.A., Lipetz, K.J., Oates, P.J., DeCherney, A.H. Diamond, M.P. (1992) Aldose reductase inhibition prevents galactose-induced ovarian dysfunction in the Sprague-Dawley rat. Obstetrics and Gynecology, 167, 1837 1843.
46. Segal, S. (1995) Galactosemia unsolved. European Journal of Pediatrics, 154, S97 S102.
47. Cramer, D.W., Harlow, B.L., Barbieri, R.L. Ng, W.G. (1989) Galactose-1-phosphate uridyl transferase activity associated with age at menopause and reproductive history. Fertility and Sterility, 51, 609 615.
48. Mlinar, B., Gersak, K., Karas, N., Zitnik, I.P., Battelino, T. Lukac-Bajalo, J. (2005) Galactose-1-phosphate uridyl transferase gene mutations in women with premature ovarian failure. Fertility and Sterility, 84, 253 255.
49. Crisponi, L., Deiana, M., Loi, A., Chiappe, F., Uda, M., Amati, P., Bisceglia, L., Zelante, L., Nagaraja, R., Porcu, S., Ristaldi, M.S., Marzella, R., Rocchi, M., Nicolino, M., Lienhardt-Roussie, A., Nivelon, A., Verloes, A., Schlessinger, D., Gasparini, P., Bonneau, D., Cao, A. Pilia, G. (2001) The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ ptosis/epicanthus inversus syndrome. Nature Genetics, 27, 159 166.
50. Uhlenhaut, N.H. Treier, M. (2006) Foxl2 function in ovarian development. Molecular Genetics and Metabolism, 88, 225 234.
51. Shelling, A.N., Burton, K.A., Chand, A.L., van Ee, C.C., France, J.T., Farquhar, C.M., Milsom, S.R., Love, D.R., Gersak, K., Aittomaki, K. Winship, I.M. (2000) Inhibin: a candidate gene for premature ovarian failure. Human Reproduction, 15, 2644 2649.
52. Barlow, C., Liyanage, M., Moens, P.B., Tarsounas, M., Nagashima, K., Brown, K., Rottinghaus, S., Jackson, S.P., Tagle, D., Ried, T. Wynshaw-Boris, A. (1998) Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I. Development, 125, 4007 4017.
53. Ellis, N.A. German, J. (1996) Molecular genetics of Bloom's syndrome. Human Molecular Genetics, 5, 1457 1463.
54. Fogli, A., Rodriguez, D., Eymard-Pierre, E., Bouhour, F., Labauge, P., Meaney, B.F., Zeesman, S., Kaneski, C.R., Schiffmann, R. Boespflug-Tanguy, O. (2003) Ovarian failure related to eukaryotic initiation factor 2B mutations. American Journal of Human Genetics, 72, 1544 1550.
55. Pagnamenta, A.T., Taanman, J.W., Wilson, C.J., Anderson, N.E., Marotta, R., Duncan, A.J., Bitner-Glindzicz, M., Taylor, R.W., Laskowski, A., Thorburn, D.R. Rahman, S. (2006) Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase γ. Human Reproduction, 21, 2467 2473.
56. Aittomaki, K., Lucena, J.L., Pakarinen, P., Sistonen, P., Tapanainen, J., Gromoll, J., Kaskikari, R., Sankila, E.M., Lehvaslaiho, H., Engel, A.R., Nieschlag, E., Huhtaniemi, I. de la Chapelle, A. (1995) Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell, 82, 959 968.
57. Latronico, A.C., Anasti, J., Arnhold, I.J.P., Rapaport, R., Mendonca, B.B., Bloise, W., Castro, M., Tsigos, C. Chrousos, G.P. (1996) Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. New England Journal of Medicine, 334, 507 512.
58. Matthews, C.H., Borgato, S., Beck-Peccoz, P., Adams, M., Tone, Y., Gambino, G., Casagrande, S., Tedeschini, G., Benedetti, A. Chatterjee, V.K. (1993) Primary amenorrhoea and infertility due to a mutation in the β-subunit of follicle-stimulating hormone. Nature Genetics, 5, 83 86.
59. Lofrano-Porto, A., Barra, G.B., Giacomini, L.A., Nascimento, P.P., Latronico, A.C., Casulari, L.A. da Rocha Neves, F.A. (2007) Luteinizing hormone β mutation and hypogonadism in men and women. New England Journal of Medicine, 357, 897 904.
60. Lin, D., Sugawara, T. Strauss, J.F. III, Clark, B.J., Stocco, D.M., Saenger, P., Rogol, A. Miller, W.L. (1995) Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science, 267, 1828 1831.
61. Mallin, S.R. (1969) Congenital adrenal hyperplasia secondary to 17-hydroxylase deficiency. Two sisters with amenorrhea, hypokalemia, hypertension, and cystic ovaries. Annals of Internal Medicine, 70, 69 75.
62. Ito, Y., Fisher, C.R., Conte, F.A., Grumbach, M.M. Simpson, E.R. (1993) Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proceedings of the National Academy of Science U.S.A., 90, 11673 11677.
63. Hoek, A., Schoemaker, J. Drexhage, H.A. (1997) Premature ovarian failure and ovarian autoimmunity. Endocrine Reviews, 18, 107 134.
64. Bakalov, V.K., Anasti, J.N., Calis, K.A., Vanderhoof, V.H., Premkumar, A., Chen, S., Furmaniak, J., Smith, B.R., Merino, M.J. Nelson, L.M. (2005) Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. Fertility and Sterility, 84, 958 965.
65. LaBarbera, A.R., Miller, M.M., Ober, C. Rebar, R.W. (1988) Autoimmune etiology in premature ovarian failure. American Journal of Reproductive Immunology and Microbiology, 16, 115 122.
66. Betterle, C., Rossi, A., Dalla, P.S., Artifoni, A., Pedini, B., Gavasso, S. Caretto, A. (1993) Premature ovarian failure: autoimmunity and natural history. Clinical Endocrinology, 39, 35 43.
67. Kim, T.J., Anasti, J.N., Flack, M.R., Kimzey, L.M., Defensor, R.A. Nelson, L.M. (1997) Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstetrics and Gynecology, 89, 777 779.
68. Bakalov, V.K., Vanderhoof, V.H., Bondy, C.A. Nelson, L.M. (2002) Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Human Reproduction, 17, 2096 2100.
69. Nagamine, K., Peterson, P. Scott, H. (1997) Positional cloning of the APECED gene. Nature Genetics, 17, 393 397.
70. The Finnish-German APECED Consortium 1997) Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nature Genetics, 17, 399 403.
71. Falorni, A., Laureti, S., Candeloro, P., Perrino, S., Coronella, C., Bizzarro, A., Bellastella, A., Santeusanio, F. De Bellis, A. (2002) Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertility and Sterility, 78, 270 279.
72. Dal Pra, C., Chen, S., Furmaniak, J., Smith, B.R., Pedini, B., Moscon, A., Zanchetta, R. Betterle, C. (2003) Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease. European Journal of Endocrinology, 148, 565 570.
73. Welt, C.K., Falorni, A., Taylor, A.E., Martin, K.A. Hall, J.E. (2005) Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol and elevated inhibin B levels. Journal of Clinical Endocrinology and Metabolism, 90, 3069 3076.
74. Gloor, E. Hurlimann, J. (1984) Autoimmune oophoritis. American Journal of Clinical Pathology, 81, 105 109.
75. Bannatyne, P., Russell, P. Shearman, R.P. (1990) Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. International Journal of Gynecological Pathology, 9, 191 207.
76. Betterle, C., Volpato, M., Rees, S.B., Furmaniak, J., Chen, S., Greggio, N.A., Sanzari, M., Tedesco, F., Pedini, B., Boscaro, M. Presotto, F. (1997) I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. Journal of Clinical Endocrinology and Metabolism, 82, 932 938.
77. Grinspoon, S.K. Biller, B.M. (1994) Clinical review 62: laboratory assessment of adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism, 79, 923 931.
78. Lass, A. (1999) The fertility potential of women with a single ovary. Human Reproduction Update, 5, 546 550.
79. Sklar, C.A., Mertens, A.C., Mitby, P., Whitton, J., Stovall, M., Kasper, C., Mulder, J., Green, D., Nicholson, H.S., Yasui, Y. Robison, L.L. (2006) Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. Journal of the National Cancer Institute, 98, 890 896.
80. Chemaitilly, W., Mertens, A.C., Mitby, P., Whitton, J., Stovall, M., Yasui, Y., Robison, L.L. Sklar, C.A. (2006) Acute ovarian failure in the childhood cancer survivor study. Journal of Clinical Endocrinology and Metabolism, 91, 1723 1728.
81. Clark, S.T., Radford, J.A., Crowther, D., Swindell, R. Shalet, S.M. (1995) Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. Journal of Clinical Oncology, 13, 134 139.
82. Meirow, D. (2000) Reproduction post-chemotherapy in young cancer patients. Molecular and Cellular Endocrinology, 169, 123 131.
83. Blumenfeld, Z., Avivi, I., Eckman, A., Epelbaum, R., Rowe, J.M. Dann, E.J. (2007) Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertility and Sterility, epub ahead of print (doi:).
84. Boldt, J., Cline, D. McLaughlin, D. (2003) Human oocyte cryopreservation as an adjunct to IVF-embryo transfer cycles. Human Reproduction, 18, 1250 1255.
85. American College of Obstetrics Gynecology 2006) Ovarian tissue and oocyte cryopreservation. Fertility and Sterility, 86, S142 S147.
86. Hawkins, M.M. (1994) Pregnancy outcome and offspring after childhood cancer. British Medical Journal, 309, 1034.
87. Sanders, J.E., Hawley, J., Levy, W., Gooley, T., Buckner, C.D., Deeg, H.J., Doney, K., Storb, R., Sullivan, K., Witherspoon, R. Appelbaum, F.R. (1996) Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 87, 3045 3052.
88. Jick, H., Porter, J. Morrison, A.S. (1977) Relation between smoking and age of natural menopause. Lancet, i, 1354 1355.
89. Matikainen, T., Perez, G.I., Juriscova, A., Pru, J.K., Schlezinger, J.J., Ryu, H.Y., Laine, J., Sakai, T., Korsmeyer, S.J., Casper, R.F., Sherr, D.H. Tilly, J.L. (2001) Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nature Genetics, 28, 355 360.
90. Barbieri, R.L., McShane, P.M. Ryan, K.J. (1986) Constituents of cigarette smoke inhibit human granulosa cell aromatase. Fertility and Sterility, 46, 232 236.
91. Scott, R.T. Jr., Hofmann, G.E., Oehninger, S. Muasher, S.J. (1990) Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertility and Sterility, 54, 297 302.
92. Conway, G.S., Kaltsas, G., Patel, A., Davies, M.C. Jacobs, H.S. (1996) Characterization of idiopathic premature ovarian failure. Fertility and Sterility, 65, 337 341.
93. Sherman, S.L. (2000) Premature ovarian failure in the fragile X syndrome. American Journal of Medical Genetics, 97, 189 194.
94. Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C., Kotchen, J.M. Ockene, J. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association, 288, 321 333.
95. Manson, J.E., Allison, M.A., Rossouw, J.E., Carr, J.J., Langer, R.D., Hsia, J., Kuller, L.H., Cochrane, B.B., Hunt, J.R., Ludlam, S.E., Pettinger, M.B., Gass, M., Margolis, K.L., Nathan, L., Ockene, J.K., Prentice, R.L., Robbins, J. Stefanick, M.L. (2007) Estrogen therapy and coronary-artery calcification. New England Journal of Medicine, 356, 2591 2602.
96. Kalantaridou, S.N., Braddock, D.T., Patronas, N.J. Nelson, L.M. (1999) Treatment of autoimmune premature ovarian failure. Human Reproduction, 14, 1777 1782.
97. Johnson, J., Canning, J., Kaneko, T., Pru, J.K. Tilly, J.L. (2004) Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature, 428, 145 150.
98. Johnson, J., Bagley, J., Skaznik-Wikiel, M., Lee, H.J., Adams, G.B., Niikura, Y., Tschudy, K.S., Tilly, J.C., Cortes, M.L., Forkert, R., Spitzer, T., Iacomini, J., Scadden, D.T. Tilly, J.L. (2005) Germline stem cells and follicular renewal in the postnatal mammalian ovary. Cell, 122, 303 315.
99. Telfer, E.E., Gosden, R.G., Byskov, A.G., Spears, N., Albertini, D., Andersen, C.Y., Anderson, R., Braw-Tal, R., Clarke, H., Gougeon, A., McLaughlin, E., McLaren, A., McNatty, K., Schatten, G., Silber, S. Tsafriri, A. (2005) On regenerating the ovary and generating controversy. Cell, 122, 821 822.
100. Veitia, R.A., Gluckman, E., Fellous, M. Soulier, J. (2007) Recovery of female fertility after chemotherapy, irradiation, and bone marrow allograft: further evidence against massive oocyte regeneration by bone marrow-derived germline stem cells. Stem Cells, 25, 1334 1335.
101. Eggan, K., Jurga, S., Gosden, R., Min, I.M. Wagers, A.J. (2006) Ovulated oocytes in adult mice derive from non-circulating germ cells. Nature, 441, 1109 1114.